董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| James C. D'Arecca | 男 | Director | 54 | 26.50万美元 | 未持股 | 2025-08-05 |
| James C. D'Arecca | 男 | Director | 54 | 未披露 | 未持股 | 2025-08-05 |
| John F. Kelly | 男 | Director | 64 | 未披露 | 未持股 | 2025-08-05 |
| John E. Byom | 男 | Independent Lead Director | 71 | 27.50万美元 | 3.48 | 2025-08-05 |
| Celeste A. Clark | 女 | Director | 72 | 26.00万美元 | 未持股 | 2025-08-05 |
| Sheila A. Hopkins | 女 | Director | 69 | 24.50万美元 | 1.03 | 2025-08-05 |
| Ronald M. Lombardi | 男 | Chair of the Board, President and Chief Executive Officer | 61 | 619.30万美元 | 33.34 | 2025-08-05 |
| Dawn M. Zier | 女 | Director | 60 | 26.50万美元 | 未持股 | 2025-08-05 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| William C. P'Pool | 男 | Senior Vice President, General Counsel and Corporate Secretary | 59 | 140.65万美元 | 2.11 | 2025-08-05 |
| Jeffrey Zerillo | 男 | Executive Vice President, Operations | 64 | 90.13万美元 | 未持股 | 2025-08-05 |
| Adel Mekhail | 男 | Executive Vice President, Marketing & Sales | 64 | 138.96万美元 | 未持股 | 2025-08-05 |
| Ronald M. Lombardi | 男 | Chair of the Board, President and Chief Executive Officer | 61 | 619.30万美元 | 33.34 | 2025-08-05 |
| Christine Sacco | 女 | Chief Financial Officer/Chief Operating Officer | 50 | 390.56万美元 | 3.61 | 2025-08-05 |
董事简历
中英对照 | 中文 | 英文- James C. D'Arecca
-
James C. D'Arecca自2013年8月起担任此职位。在加入Allergan之前，他在Bausch + Lomb担任过类似的职位。 在加入Bausch + Lomb之前，D'Arecca先生曾在Merck＆Co.和先灵葆雅工作。 他还在普华永道会计师事务所担任了13年的注册会计师。 D'Arecca先生获得了哥伦比亚大学的MBA学位和他的学士学位。 在罗格斯大学会计学。
James C. D'Arecca was appointed Chief Accounting Officer - Global, on August 7 2013. Prior to joining Actavis, Mr. D'Arecca held a similar position at Bausch & Lomb. Prior to joining Bausch & Lomb, Mr. D'Arecca worked for Merck & Co., Inc. where he was Executive Director and Business Development Controller responsible for being the primary liaison between the Controller's organization and the business development and corporate licensing functions. Prior to joining Merck, Mr. D'Arecca was Executive Director and Assistant Controller at Schering-Plough. Mr. D'Arecca also spent 13 years with PricewaterhouseCoopers as a Certified Public Accountant. Mr. D'Arecca received his MBA from Columbia University and his BS in Accounting from Rutgers University. - James C. D'Arecca自2013年8月起担任此职位。在加入Allergan之前，他在Bausch + Lomb担任过类似的职位。 在加入Bausch + Lomb之前，D'Arecca先生曾在Merck＆Co.和先灵葆雅工作。 他还在普华永道会计师事务所担任了13年的注册会计师。 D'Arecca先生获得了哥伦比亚大学的MBA学位和他的学士学位。 在罗格斯大学会计学。
- James C. D'Arecca was appointed Chief Accounting Officer - Global, on August 7 2013. Prior to joining Actavis, Mr. D'Arecca held a similar position at Bausch & Lomb. Prior to joining Bausch & Lomb, Mr. D'Arecca worked for Merck & Co., Inc. where he was Executive Director and Business Development Controller responsible for being the primary liaison between the Controller's organization and the business development and corporate licensing functions. Prior to joining Merck, Mr. D'Arecca was Executive Director and Assistant Controller at Schering-Plough. Mr. D'Arecca also spent 13 years with PricewaterhouseCoopers as a Certified Public Accountant. Mr. D'Arecca received his MBA from Columbia University and his BS in Accounting from Rutgers University.
- James C. D'Arecca
-
James C. D'Arecca，自2023年8月起担任董事；自2022年4月起担任医疗技术公司Haemonetics Corporation的执行副总裁兼首席财务官；此前曾于2020年6月至2022年4月担任女性医疗保健公司TherapeuticSMD，Inc.的首席财务官；自2013年8月起担任全球制药公司Allergen PLC（原名Actavis PLC）的高级副总裁兼首席会计官，在加入TherapeuticSMD之前，该公司于2020年5月与AbbVie Inc.合并，Inc.；在加入阿特维斯公司之前曾在博士伦公司担任首席会计官；在其职业生涯早期曾在默沙东公司和Schering-Plough Corporation担任财务和业务发展职务，职责日益增加；1992-2005年在普华永道会计师事务所开始其职业生涯，在那里他的行业重点是药品、医疗器械和消费品。达雷卡获得了罗格斯大学会计学理学学士学位和哥伦比亚大学工商管理硕士学位。他是注册会计师。
James C. D'Arecca,has served as a director since August 2023;Has been Executive Vice President, Chief Financial Officer of Haemonetics Corporation, a medical technology company, since April 2022;Previously served as Chief Financial Officer of TherapeuticsMD, Inc., a women's healthcare company, from June 2020 to April 2022;Served as the Senior Vice President and Chief Accounting Officer of Allergen plc (formerly known as Actavis plc), a global pharmaceutical company, from August 2013 until its merger with AbbVie Inc. in May 2020, prior to joining TherapeuticsMD, Inc.;Served as Chief Accounting Officer at Bausch & Lomb prior to joining Actavis plc;Held finance and business development positions of increasing responsibility at Merck & Co., Inc. and Schering-Plough Corporation earlier in his career;Began his career at PricewaterhouseCoopers LLP from 1992 to 2005, where he had an industry focus on pharmaceuticals, medical devices, and consumer products.Mr. D'Arecca earned a Bachelor of Science in Accounting from Rutgers University and a Master of Business Administration from Columbia University. He is a Certified Public Accountant. - James C. D'Arecca，自2023年8月起担任董事；自2022年4月起担任医疗技术公司Haemonetics Corporation的执行副总裁兼首席财务官；此前曾于2020年6月至2022年4月担任女性医疗保健公司TherapeuticSMD，Inc.的首席财务官；自2013年8月起担任全球制药公司Allergen PLC（原名Actavis PLC）的高级副总裁兼首席会计官，在加入TherapeuticSMD之前，该公司于2020年5月与AbbVie Inc.合并，Inc.；在加入阿特维斯公司之前曾在博士伦公司担任首席会计官；在其职业生涯早期曾在默沙东公司和Schering-Plough Corporation担任财务和业务发展职务，职责日益增加；1992-2005年在普华永道会计师事务所开始其职业生涯，在那里他的行业重点是药品、医疗器械和消费品。达雷卡获得了罗格斯大学会计学理学学士学位和哥伦比亚大学工商管理硕士学位。他是注册会计师。
- James C. D'Arecca,has served as a director since August 2023;Has been Executive Vice President, Chief Financial Officer of Haemonetics Corporation, a medical technology company, since April 2022;Previously served as Chief Financial Officer of TherapeuticsMD, Inc., a women's healthcare company, from June 2020 to April 2022;Served as the Senior Vice President and Chief Accounting Officer of Allergen plc (formerly known as Actavis plc), a global pharmaceutical company, from August 2013 until its merger with AbbVie Inc. in May 2020, prior to joining TherapeuticsMD, Inc.;Served as Chief Accounting Officer at Bausch & Lomb prior to joining Actavis plc;Held finance and business development positions of increasing responsibility at Merck & Co., Inc. and Schering-Plough Corporation earlier in his career;Began his career at PricewaterhouseCoopers LLP from 1992 to 2005, where he had an industry focus on pharmaceuticals, medical devices, and consumer products.Mr. D'Arecca earned a Bachelor of Science in Accounting from Rutgers University and a Master of Business Administration from Columbia University. He is a Certified Public Accountant.
- John F. Kelly
-
John F. Kelly，是Wakeman Boys & Girls Club董事会主席，也是伍斯特理工学院工程院长顾问委员会成员；在生物制药公司辉瑞公司工作了40年后，于2022年6月退休，他曾是辉瑞全球供应领导团队成员和辉瑞 PAC董事会成员；从1982年8月开始在辉瑞担任过多个职业生涯，最后担任质量运营和环境、健康与安全副总裁。在辉瑞，Kelly先生的职责包括药品和消费品运营、制造战略、业务发展、质量和EHS；在2019年3月至2022年6月期间担任Zydus Cadila Oncology Private Limited的董事会主席，该公司是辉瑞和Zydus Cadila的50/50合资企业，在此之前，他在2015年12月至2019年3月期间担任该公司的董事；曾是康涅狄格州费尔菲尔德市帕特森俱乐部的董事会成员以及费尔菲尔德学院预科学校父亲俱乐部的联合主席。
John F. Kelly,Is Chair of the Board of Trustees of Wakeman Boys & Girls Club, and a member of the Worcester Polytechnic Institute Engineering Dean's Advisory Board;Retired in June 2022 after a 40-year career at Pfizer Inc., a biopharmaceutical company, where he was a member of the Pfizer Global Supply Leadership Team and a member of the Pfizer PAC Board of Directors;Held multiple positions in his career with Pfizer starting in August 1982 and finishing as the Vice President, Quality Operations and Environment, Health & Safety. At Pfizer, Mr. Kelly's responsibilities included pharmaceutical and consumer product operations, manufacturing strategy, business development, quality and EHS;Served as Chair of the Board of Directors of Zydus Cadila Oncology Private Limited, a 50/50 joint venture between Pfizer and Zydus Cadila, between March 2019 and June 2022, and prior to that he was a director of same between December 2015 and March 2019;Was a member of the Board of Directors of The Patterson Club, Fairfield, CT and co-President of the Fairfield College Preparatory School Father's Club. - John F. Kelly，是Wakeman Boys & Girls Club董事会主席，也是伍斯特理工学院工程院长顾问委员会成员；在生物制药公司辉瑞公司工作了40年后，于2022年6月退休，他曾是辉瑞全球供应领导团队成员和辉瑞 PAC董事会成员；从1982年8月开始在辉瑞担任过多个职业生涯，最后担任质量运营和环境、健康与安全副总裁。在辉瑞，Kelly先生的职责包括药品和消费品运营、制造战略、业务发展、质量和EHS；在2019年3月至2022年6月期间担任Zydus Cadila Oncology Private Limited的董事会主席，该公司是辉瑞和Zydus Cadila的50/50合资企业，在此之前，他在2015年12月至2019年3月期间担任该公司的董事；曾是康涅狄格州费尔菲尔德市帕特森俱乐部的董事会成员以及费尔菲尔德学院预科学校父亲俱乐部的联合主席。
- John F. Kelly,Is Chair of the Board of Trustees of Wakeman Boys & Girls Club, and a member of the Worcester Polytechnic Institute Engineering Dean's Advisory Board;Retired in June 2022 after a 40-year career at Pfizer Inc., a biopharmaceutical company, where he was a member of the Pfizer Global Supply Leadership Team and a member of the Pfizer PAC Board of Directors;Held multiple positions in his career with Pfizer starting in August 1982 and finishing as the Vice President, Quality Operations and Environment, Health & Safety. At Pfizer, Mr. Kelly's responsibilities included pharmaceutical and consumer product operations, manufacturing strategy, business development, quality and EHS;Served as Chair of the Board of Directors of Zydus Cadila Oncology Private Limited, a 50/50 joint venture between Pfizer and Zydus Cadila, between March 2019 and June 2022, and prior to that he was a director of same between December 2015 and March 2019;Was a member of the Board of Directors of The Patterson Club, Fairfield, CT and co-President of the Fairfield College Preparatory School Father's Club.
- John E. Byom
-
John E. Byom， 他一直担任董事（自2006年1月以来）。他目前是Classic Provisions公司（专业食品销售公司，他于2007年10月加入公司）的首席执行官。他此前曾担任International Multifoods Corporation的首席财务官。他于2005年3月退任International Multifoods Corporation（他曾任职该公司26年），包括担任财务副总裁兼首席财务官4年（从2000年3月到2004年6月）。2004年6月，International Multifoods Corporation出售给The J.M.Smucker Company。此后，他曾担任Multifoods Foodservice公司和Bakery Products公司的总裁。担任首席财务官之前，他曾担任美国制造业务总裁（从1999年7月到2000年3月），以及公司北美食品部门的财务和信息副总裁（从1993年到1999年）。1993年之前，他曾担任多种财务职务，也曾担任International Multifoods Corporation的内部审计师（从1979年到1981年）。他持有Luther College的会计学士学位。他曾担任MGP Ingredients公司的董事（从2004年到2013年12月）。
John E. Byom,has served as a director since January 2006Was Chief Executive Officer of Classic Provisions Inc., a specialty foods distribution company, from October 2007 until the business was sold and he retired in June 2019;Was previously the Chief Financial Officer of International Multifoods Corporation. He left International Multifoods Corporation in March 2005 after 26 years, including four years as Vice President Finance and Chief Financial Officer from March 2000 to June 2004;Was President of Multifoods Foodservice and Bakery Products from June 2004 until March 2005 after the sale of International Multifoods Corporation to The J.M. Smucker Company in June 2004;Was President of U.S. Manufacturing from July 1999 to March 2000, and Vice President Finance and IT for the North American Foods Division from 1993 to 1999, prior to his time as Chief Financial Officer and as President of Multifoods Foodservice and Bakery Products;Prior to 1993, held various positions in finance and was an internal auditor for International Multifoods Corporation from 1979 to 1981.Mr. Byom earned his B.A. in Accounting from Luther College. - John E. Byom， 他一直担任董事（自2006年1月以来）。他目前是Classic Provisions公司（专业食品销售公司，他于2007年10月加入公司）的首席执行官。他此前曾担任International Multifoods Corporation的首席财务官。他于2005年3月退任International Multifoods Corporation（他曾任职该公司26年），包括担任财务副总裁兼首席财务官4年（从2000年3月到2004年6月）。2004年6月，International Multifoods Corporation出售给The J.M.Smucker Company。此后，他曾担任Multifoods Foodservice公司和Bakery Products公司的总裁。担任首席财务官之前，他曾担任美国制造业务总裁（从1999年7月到2000年3月），以及公司北美食品部门的财务和信息副总裁（从1993年到1999年）。1993年之前，他曾担任多种财务职务，也曾担任International Multifoods Corporation的内部审计师（从1979年到1981年）。他持有Luther College的会计学士学位。他曾担任MGP Ingredients公司的董事（从2004年到2013年12月）。
- John E. Byom,has served as a director since January 2006Was Chief Executive Officer of Classic Provisions Inc., a specialty foods distribution company, from October 2007 until the business was sold and he retired in June 2019;Was previously the Chief Financial Officer of International Multifoods Corporation. He left International Multifoods Corporation in March 2005 after 26 years, including four years as Vice President Finance and Chief Financial Officer from March 2000 to June 2004;Was President of Multifoods Foodservice and Bakery Products from June 2004 until March 2005 after the sale of International Multifoods Corporation to The J.M. Smucker Company in June 2004;Was President of U.S. Manufacturing from July 1999 to March 2000, and Vice President Finance and IT for the North American Foods Division from 1993 to 1999, prior to his time as Chief Financial Officer and as President of Multifoods Foodservice and Bakery Products;Prior to 1993, held various positions in finance and was an internal auditor for International Multifoods Corporation from 1979 to 1981.Mr. Byom earned his B.A. in Accounting from Luther College.
- Celeste A. Clark
-
Celeste A. Clark是Abraham Clark Consulting的独立董事和负责人，该公司是她于2011年创立的健康和监管政策咨询公司。她在全球公共政策和可持续发展方面拥有丰富的经验，此前曾在家乐氏公司担任公共政策全球主管兼首席可持续发展官（2004-2011年），在那里她领导了180个市场的健康/营养计划，并建立了公司的可持续发展框架，以及The Simply Good Foods Company，此前曾在AdvantAge Health Holdings和Omega Protein Corporation等董事会任职。
Celeste A. Clark has been a director since September 2017. Dr. Clark has been the principal of Abraham Clark Consulting, LLC, a consulting firm, since November 2011 and consults on nutrition and health policy, regulatory affairs and leadership development. Dr. Clark is an adjunct professor at Michigan State University where she earned her doctorate in Food Science and was also recently bestod an honorary doctorate of Humanities for her community engagement work. She previoly served as Senior Vice President, Global Policy and External Affairs of Kellogg Company, a food manufacturing company, and was the Chief Stainability Officer until she retired in 2011. She was a member of the Global Executive Management Team and had an accomplished career spanning nearly 35 years in the food indtry. At Kellogg Company, she was responsible for the development and implementation of health, nutrition and regulatory science initiatives globally to ensure consistency in approach and implementation. In addition, she also led global corporate communications, government relations, philanthropy and several administrative functions. Dr. Clark serves as an independent director on boards of public, private and not for profit entities. She was recently recognized as a Directorship 100 honoree by the National Association of Corporate Directors in 2023 and was recognized as one of "100 Black Board Members Making a Difference" by BoardProspects in 2024. - Celeste A. Clark是Abraham Clark Consulting的独立董事和负责人，该公司是她于2011年创立的健康和监管政策咨询公司。她在全球公共政策和可持续发展方面拥有丰富的经验，此前曾在家乐氏公司担任公共政策全球主管兼首席可持续发展官（2004-2011年），在那里她领导了180个市场的健康/营养计划，并建立了公司的可持续发展框架，以及The Simply Good Foods Company，此前曾在AdvantAge Health Holdings和Omega Protein Corporation等董事会任职。
- Celeste A. Clark has been a director since September 2017. Dr. Clark has been the principal of Abraham Clark Consulting, LLC, a consulting firm, since November 2011 and consults on nutrition and health policy, regulatory affairs and leadership development. Dr. Clark is an adjunct professor at Michigan State University where she earned her doctorate in Food Science and was also recently bestod an honorary doctorate of Humanities for her community engagement work. She previoly served as Senior Vice President, Global Policy and External Affairs of Kellogg Company, a food manufacturing company, and was the Chief Stainability Officer until she retired in 2011. She was a member of the Global Executive Management Team and had an accomplished career spanning nearly 35 years in the food indtry. At Kellogg Company, she was responsible for the development and implementation of health, nutrition and regulatory science initiatives globally to ensure consistency in approach and implementation. In addition, she also led global corporate communications, government relations, philanthropy and several administrative functions. Dr. Clark serves as an independent director on boards of public, private and not for profit entities. She was recently recognized as a Directorship 100 honoree by the National Association of Corporate Directors in 2023 and was recognized as one of "100 Black Board Members Making a Difference" by BoardProspects in 2024.
- Sheila A. Hopkins
-
SheilaA.Hopkins，董事，自2015年8月起担任董事。Hopkins从2011年9月到2013年8月退休担任Bausch+Lomb（一家梦百合公司）执行Vice President和Bausch+Lomb全球视野护理总裁。在此之前，1997年9月至2011年8月，她在消费品公司高露洁棕榄（Colgate-Palmolive）工作了14年，担任过多个高级管理职位，包括Vice President和个人护理总经理，以及全球业务发展Vice President。在此之前，她曾在宝洁公司、美国氰氨公司和Tambrands公司担任重要的市场营销与销售职位。Hopkins女士在Wellesley College获得历史学学士学位。Hopkins从2003年到2013年担任Warnaco Inc.（一家领先的服装公司）董事。她也曾任职于消费者梦百合产品协会的董事会，曾担任Bausch+Lomb公司的执行Vice President，以及Bausch+Lomb公司的全球视力保健总裁，也曾担任高露洁棕榄公司的Vice President兼个人护理总经理。曾担任Bausch+Lomb公司的执行Vice President和Bausch+Lomb公司的全球视力保健总裁；在高露洁棕榄公司有14年的经验，包括担任高露洁棕榄公司的Vice President兼个人护理和Vice President、全球业务发展总经理。
Sheila A. Hopkins,has served as a director since August 2015;Formerly served as the Interim Chief Executive Officer of Cutera, Inc., an energy based and aesthetic devices company, from April 2023 to August 2023. Cutera, Inc. filed Chapter 11 Bankruptcy in March 2025;Previously served as President, Global Vision Care and Executive Vice President of Bausch + Lomb, a healthcare company, from September 2011 until her retirement in August 2013;Worked at Colgate-Palmolive, a leading consumer products company, where she held several senior executive positions including Vice President and General Manager, Personal Care, Vice President, Global Business Development and Vice President and General Manager, Professional Oral Care, from September 1997 to August 2011;Held significant marketing and sales positions at Procter & Gamble, American Cyanamid, and Tambrands, prior to joining Colgate-Palmolive;Served on the boards of the Consumer Healthcare Products Association and the American Dental Association Foundation;Ms. Hopkins earned a B.A. in History from Wellesley College. - SheilaA.Hopkins，董事，自2015年8月起担任董事。Hopkins从2011年9月到2013年8月退休担任Bausch+Lomb（一家梦百合公司）执行Vice President和Bausch+Lomb全球视野护理总裁。在此之前，1997年9月至2011年8月，她在消费品公司高露洁棕榄（Colgate-Palmolive）工作了14年，担任过多个高级管理职位，包括Vice President和个人护理总经理，以及全球业务发展Vice President。在此之前，她曾在宝洁公司、美国氰氨公司和Tambrands公司担任重要的市场营销与销售职位。Hopkins女士在Wellesley College获得历史学学士学位。Hopkins从2003年到2013年担任Warnaco Inc.（一家领先的服装公司）董事。她也曾任职于消费者梦百合产品协会的董事会，曾担任Bausch+Lomb公司的执行Vice President，以及Bausch+Lomb公司的全球视力保健总裁，也曾担任高露洁棕榄公司的Vice President兼个人护理总经理。曾担任Bausch+Lomb公司的执行Vice President和Bausch+Lomb公司的全球视力保健总裁；在高露洁棕榄公司有14年的经验，包括担任高露洁棕榄公司的Vice President兼个人护理和Vice President、全球业务发展总经理。
- Sheila A. Hopkins,has served as a director since August 2015;Formerly served as the Interim Chief Executive Officer of Cutera, Inc., an energy based and aesthetic devices company, from April 2023 to August 2023. Cutera, Inc. filed Chapter 11 Bankruptcy in March 2025;Previously served as President, Global Vision Care and Executive Vice President of Bausch + Lomb, a healthcare company, from September 2011 until her retirement in August 2013;Worked at Colgate-Palmolive, a leading consumer products company, where she held several senior executive positions including Vice President and General Manager, Personal Care, Vice President, Global Business Development and Vice President and General Manager, Professional Oral Care, from September 1997 to August 2011;Held significant marketing and sales positions at Procter & Gamble, American Cyanamid, and Tambrands, prior to joining Colgate-Palmolive;Served on the boards of the Consumer Healthcare Products Association and the American Dental Association Foundation;Ms. Hopkins earned a B.A. in History from Wellesley College.
- Ronald M. Lombardi
-
Ronald M. Lombardi，他是首席财务官，曾一直担任公司的首席财务官（2010年12月以来）。加入公司之前，他曾任职Medtech Group Holdings公司（组件和合同医疗设备制造商），担任首席财务官（从2010年10月到2010年12月）。从2009年10月到2010年10月，他曾担任 Waterbury International Holdings公司（特种化工和害虫控制业务）的首席财务官。他曾任职Cannondale Sports Group（体育用品和服装制造公司），担任首席运营官（从2008年8月到2009年10月），以及高级副总裁兼首席财务官（从2004年3月到2008年8月）。从2000年到2004年，他曾担任Gerber Scientific公司的多种职务，包括Gerber Scientific公司的戈贝尔科伯恩光学部门的副总裁兼首席财务官，以及Gerber Scientific公司的财务预算及分析董事。他此前曾任职Emerson Electric公司、Scovill Fasteners公司、Go/Dan Industries公司。他持有Springfield College的学士学位，以及American International College的工商管理硕士学位。他是注册会计师。
Ronald M. Lombardi,Elected Chair of the Board in May 2017 and has served as a director and as President and Chief Executive Officer of the Company since June 2015;Served as Chief Financial Officer of the Company from December 2010 until November 2015;Employed by Medtech Group Holdings, a components and contract medical device manufacturer, as Chief Financial Officer, prior to joining the Company, from October 2010 to December 2010;Served as the Chief Financial Officer of Waterbury International Holdings, a specialty chemical and pest control business, from October 2009 to October 2010;Employed by Cannondale Sports Group, a sporting goods and apparel manufacturing company, as Chief Operating Officer from August 2008 to October 2009 and as Senior Vice President and Chief Financial Officer from March 2004 to August 2008;Served in various roles at Gerber Scientific Inc., including Vice President and Chief Financial Officer of Gerber Scientific Inc.'s Gerber Coburn Optical Division and Director of Financial Planning and Analysis from 2000 to 2004;Previously employed by Emerson Electric, Scovill Fasteners, Inc. and Go/Dan Industries;Mr. Lombardi earned a B.S. from Springfield College and an M.B.A. from American International College and has been a licensed CPA. - Ronald M. Lombardi，他是首席财务官，曾一直担任公司的首席财务官（2010年12月以来）。加入公司之前，他曾任职Medtech Group Holdings公司（组件和合同医疗设备制造商），担任首席财务官（从2010年10月到2010年12月）。从2009年10月到2010年10月，他曾担任 Waterbury International Holdings公司（特种化工和害虫控制业务）的首席财务官。他曾任职Cannondale Sports Group（体育用品和服装制造公司），担任首席运营官（从2008年8月到2009年10月），以及高级副总裁兼首席财务官（从2004年3月到2008年8月）。从2000年到2004年，他曾担任Gerber Scientific公司的多种职务，包括Gerber Scientific公司的戈贝尔科伯恩光学部门的副总裁兼首席财务官，以及Gerber Scientific公司的财务预算及分析董事。他此前曾任职Emerson Electric公司、Scovill Fasteners公司、Go/Dan Industries公司。他持有Springfield College的学士学位，以及American International College的工商管理硕士学位。他是注册会计师。
- Ronald M. Lombardi,Elected Chair of the Board in May 2017 and has served as a director and as President and Chief Executive Officer of the Company since June 2015;Served as Chief Financial Officer of the Company from December 2010 until November 2015;Employed by Medtech Group Holdings, a components and contract medical device manufacturer, as Chief Financial Officer, prior to joining the Company, from October 2010 to December 2010;Served as the Chief Financial Officer of Waterbury International Holdings, a specialty chemical and pest control business, from October 2009 to October 2010;Employed by Cannondale Sports Group, a sporting goods and apparel manufacturing company, as Chief Operating Officer from August 2008 to October 2009 and as Senior Vice President and Chief Financial Officer from March 2004 to August 2008;Served in various roles at Gerber Scientific Inc., including Vice President and Chief Financial Officer of Gerber Scientific Inc.'s Gerber Coburn Optical Division and Director of Financial Planning and Analysis from 2000 to 2004;Previously employed by Emerson Electric, Scovill Fasteners, Inc. and Go/Dan Industries;Mr. Lombardi earned a B.S. from Springfield College and an M.B.A. from American International College and has been a licensed CPA.
- Dawn M. Zier
-
Dawn M. Zier自2017年9月起担任董事。自2020年2月以来，Zier女士一直担任Aurora Business Consulting,LLC的负责人，就业务转型、数字/营销加速和高绩效团队为上市公司和私营公司提供建议。2012年11月至2019年3月被Tivity Health, Inc.收购之前，Zier女士曾担任Nutrisystem, Inc.（一家领先的减肥解决方案和服务提供商）的总裁兼首席执行官和董事会成员，随后，Zier女士继续在Tivity Health（一家领先的营养、健身和社交参与解决方案提供商）担任总裁/COO并担任董事会成员，以帮助推进整合工作至2019年12月。2011年4月至2012年11月，Zier女士担任读者文摘协会国际总裁，该协会是一家全球性媒体和直接营销公司。2013年2月，RDA控股公司，即读者文摘协会的控股公司和母公司，根据《美国破产法》第11章提交了重组救济自愿申请。Zier女士曾担任多个营销和媒体实体的董事会成员和委员会主席，包括2008年至2015年担任数据和营销协会（DMA）董事会成员和执行委员会成员的Data and Marketing Association（DMA）董事会成员。Zier女士在麻省理工学院获得工商管理硕士和工程硕士学位。
Dawn M. Zier,has been a director since September 2017 and has been Chair of the Board since November 2022. Since February 2020, Ms. Zier has been the principal of Aurora Business Consulting, LLC, and advises public and private companies and executives on business transformation, digital/ marketing acceleration, leadership, and high-performance teams. Ms. Zier was the President and CEO and a member of the board of directors of Nutrisystem, Inc., a leading direct-to-consumer/ecommerce provider of weight loss solutions and services, from November 2012 until its March 2019 acquisition by Tivity Health, Inc. Ms. Zier then continued with Tivity Health, a leading provider of fitness and social engagement solutions, serving as President/COO and a member of its board of directors, to help with the integration efforts through December 2019. Prior to Nutrisystem, she served in a variety of executive positions at Reader's Digest Association, a global media and data marketing company, including President of International from 2011-2012, President of Europe from 2009-2011, President of Global Consumer Marketing from 2008-2009, and President of North America Consumer Marketing from 2005-2008. Ms. Zier also serves on the board of Prestige Consumer Healthcare Inc., where she chairs the Compensation Committee. Ms. Zier has previously served on several other public and private company boards where she has chaired Nominating and Governance, Compensation, and Special Committees. She has also served on the boards of multiple marketing and media entities, including the Data and Marketing Association's (DMA) board from 2008 to 2015, where she was a voting director and on the executive committee. Ms. Zier is an executive mentor to Fortune 500 senior executives through her work with The ExCo Group, a firm of experienced CEOs, board directors, and global business leaders who has real world experience to coaching and leadership development. Ms. Zier earned her MBA and Master of Engineering from the Massachusetts Institute of Technology. Additionally, she has received her Corporate Director Certification from Harvard Business School in 2020 and a certificate in Artificial Intelligence: Implications for Business Strategy from MIT Sloan School of Management in 2025. - Dawn M. Zier自2017年9月起担任董事。自2020年2月以来，Zier女士一直担任Aurora Business Consulting,LLC的负责人，就业务转型、数字/营销加速和高绩效团队为上市公司和私营公司提供建议。2012年11月至2019年3月被Tivity Health, Inc.收购之前，Zier女士曾担任Nutrisystem, Inc.（一家领先的减肥解决方案和服务提供商）的总裁兼首席执行官和董事会成员，随后，Zier女士继续在Tivity Health（一家领先的营养、健身和社交参与解决方案提供商）担任总裁/COO并担任董事会成员，以帮助推进整合工作至2019年12月。2011年4月至2012年11月，Zier女士担任读者文摘协会国际总裁，该协会是一家全球性媒体和直接营销公司。2013年2月，RDA控股公司，即读者文摘协会的控股公司和母公司，根据《美国破产法》第11章提交了重组救济自愿申请。Zier女士曾担任多个营销和媒体实体的董事会成员和委员会主席，包括2008年至2015年担任数据和营销协会（DMA）董事会成员和执行委员会成员的Data and Marketing Association（DMA）董事会成员。Zier女士在麻省理工学院获得工商管理硕士和工程硕士学位。
- Dawn M. Zier,has been a director since September 2017 and has been Chair of the Board since November 2022. Since February 2020, Ms. Zier has been the principal of Aurora Business Consulting, LLC, and advises public and private companies and executives on business transformation, digital/ marketing acceleration, leadership, and high-performance teams. Ms. Zier was the President and CEO and a member of the board of directors of Nutrisystem, Inc., a leading direct-to-consumer/ecommerce provider of weight loss solutions and services, from November 2012 until its March 2019 acquisition by Tivity Health, Inc. Ms. Zier then continued with Tivity Health, a leading provider of fitness and social engagement solutions, serving as President/COO and a member of its board of directors, to help with the integration efforts through December 2019. Prior to Nutrisystem, she served in a variety of executive positions at Reader's Digest Association, a global media and data marketing company, including President of International from 2011-2012, President of Europe from 2009-2011, President of Global Consumer Marketing from 2008-2009, and President of North America Consumer Marketing from 2005-2008. Ms. Zier also serves on the board of Prestige Consumer Healthcare Inc., where she chairs the Compensation Committee. Ms. Zier has previously served on several other public and private company boards where she has chaired Nominating and Governance, Compensation, and Special Committees. She has also served on the boards of multiple marketing and media entities, including the Data and Marketing Association's (DMA) board from 2008 to 2015, where she was a voting director and on the executive committee. Ms. Zier is an executive mentor to Fortune 500 senior executives through her work with The ExCo Group, a firm of experienced CEOs, board directors, and global business leaders who has real world experience to coaching and leadership development. Ms. Zier earned her MBA and Master of Engineering from the Massachusetts Institute of Technology. Additionally, she has received her Corporate Director Certification from Harvard Business School in 2020 and a certificate in Artificial Intelligence: Implications for Business Strategy from MIT Sloan School of Management in 2025.
高管简历
中英对照 | 中文 | 英文- William C. P'Pool
William C.P’Pool，高级副总裁，总法律顾问兼公司秘书，于2016年11月被任命为公司高级副总裁，总法律顾问兼公司秘书。从2004年6月到2015年4月，P’Pool先生担任美赞臣营养品有限公司的高级副总裁，总法律顾问兼公司秘书。P’Pool从2001年5月到2004年6月担任Yum！Brands，Inc.从1991年到2001年，他曾担任GrafTech International公司（服务商品公司）的法律职务，并不断被提拔。他在Murray State University获得商业学士学位，在University of Kentucky获得法学博士学位。
William C. P'Pool,was appointed to the position of Senior Vice President, General Counsel and Corporate Secretary for the Company in November 2016. From June 2004 to April 2015, Mr. P'Pool served in progressive leadership roles at Mead Johnson Nutrition Company, a nutritional products company, the last being Senior Vice President, General Counsel and Corporate Secretary. From May 2001 to June 2004, Mr. P'Pool served as a Senior Counsel and Director of Legal Services at Yum! Brands, Inc. From 1991 to 2001, he served in legal roles of increasing responsibility at GrafTech International and Service Merchandise Company, among others. He earned a B.S. in business from Murray State University and a J.D. from the University of Kentucky.- William C.P’Pool，高级副总裁，总法律顾问兼公司秘书，于2016年11月被任命为公司高级副总裁，总法律顾问兼公司秘书。从2004年6月到2015年4月，P’Pool先生担任美赞臣营养品有限公司的高级副总裁，总法律顾问兼公司秘书。P’Pool从2001年5月到2004年6月担任Yum！Brands，Inc.从1991年到2001年，他曾担任GrafTech International公司（服务商品公司）的法律职务，并不断被提拔。他在Murray State University获得商业学士学位，在University of Kentucky获得法学博士学位。
- William C. P'Pool,was appointed to the position of Senior Vice President, General Counsel and Corporate Secretary for the Company in November 2016. From June 2004 to April 2015, Mr. P'Pool served in progressive leadership roles at Mead Johnson Nutrition Company, a nutritional products company, the last being Senior Vice President, General Counsel and Corporate Secretary. From May 2001 to June 2004, Mr. P'Pool served as a Senior Counsel and Director of Legal Services at Yum! Brands, Inc. From 1991 to 2001, he served in legal roles of increasing responsibility at GrafTech International and Service Merchandise Company, among others. He earned a B.S. in business from Murray State University and a J.D. from the University of Kentucky.
- Jeffrey Zerillo
Jeffrey Zerillo，高级副总裁，业务，自2018年4月起担任公司高级副总裁，业务。泽里略先生从制药公司梯瓦制药（Teva Pharmaceuticals）加入该公司，并于2016年至2018年担任美国地区供应链管理Vice President。他在宾夕法尼亚约克学院（York College of Pennsylvania）获得企业管理-生产运营学士学位，并在斯隆商学院（Sloan School of Business）获得高管证书。
Jeffrey Zerillo,was appointed to the position of Senior Vice President, Operations for the Company in April 2018. Mr. Zerillo joined the Company from Teva Pharmaceuticals, a pharmaceutical company, where he served as Vice President, Supply Chain Management for the America's Region from 2016 to 2018. He brings experience managing complex supply chains in pharmaceuticals, biologics and medical devices from companies including Actavis/Allergan, a pharmaceutical company, from 2014 to 2016, Purdue Pharma from 1995 to 2013, Tura L.P. from 1994 to 1995 and Instrumentation Laboratories from 1988 to 1994. He earned a B.S. in Business Management - Production Operations from York College of Pennsylvania and an Executive Certificate from Sloan School of Business.- Jeffrey Zerillo，高级副总裁，业务，自2018年4月起担任公司高级副总裁，业务。泽里略先生从制药公司梯瓦制药（Teva Pharmaceuticals）加入该公司，并于2016年至2018年担任美国地区供应链管理Vice President。他在宾夕法尼亚约克学院（York College of Pennsylvania）获得企业管理-生产运营学士学位，并在斯隆商学院（Sloan School of Business）获得高管证书。
- Jeffrey Zerillo,was appointed to the position of Senior Vice President, Operations for the Company in April 2018. Mr. Zerillo joined the Company from Teva Pharmaceuticals, a pharmaceutical company, where he served as Vice President, Supply Chain Management for the America's Region from 2016 to 2018. He brings experience managing complex supply chains in pharmaceuticals, biologics and medical devices from companies including Actavis/Allergan, a pharmaceutical company, from 2014 to 2016, Purdue Pharma from 1995 to 2013, Tura L.P. from 1994 to 1995 and Instrumentation Laboratories from 1988 to 1994. He earned a B.S. in Business Management - Production Operations from York College of Pennsylvania and an Executive Certificate from Sloan School of Business.
- Adel Mekhail
Adel Mekhail，营销与销售执行Vice President，于2019年5月被任命为公司营销与销售执行Vice President。2017年4月至2018年7月，Mekhail先生担任个人护理产品公司Edgewell Personal Care的美洲Vice President。他曾于2015年7月至2017年4月担任Edgewell Personal Care拉丁美洲私人品牌集团和Vice President的Vice President兼总经理。Mekhail从2013年11月到2015年7月担任Energizer亚太区Vice President，该公司被Edgewell收购。他从2003年到2013年在Energizer担任其他越来越负责的营销角色。Mekhail先生还从1996年到2003年在辉瑞公司和Warner Lambert公司担任销售与市场营销职务。2000年，他为辉瑞公司从澳大利亚搬到美国。Mekhail先生在埃及坦塔大学（Tanta University）获得制药科学学士学位，并在澳大利亚墨尔本的RMIT大学（RMIT University）获得工商管理硕士学位。
Adel Mekhail,was appointed to the position of Executive Vice President of Marketing & Sales for the Company in May 2019. From April 2017 to July 2018, Mr. Mekhail served as Vice President, Americas at Edgewell Personal Care Company, a personal care products company, and from July 2015 to April 2017 he served as Vice President and General Manager, Private Brands Group and Vice President, Latin America. From November 2013 to July 2015, Mr. Mekhail served as Vice President, Asia Pacific at Energizer. He held other increasingly responsible marketing roles at Energizer from 2003 to 2013. Mr. Mekhail also served in sales and marketing roles for Pfizer and Warner Lambert from 1996 to 2003. In 2000, he moved from Australia to the United States for Pfizer. Mr. Mekhail earned his B.S. in Pharmaceutical Sciences from Tanta University in Egypt and his M.B.A. from RMIT University in Melbourne, Australia.- Adel Mekhail，营销与销售执行Vice President，于2019年5月被任命为公司营销与销售执行Vice President。2017年4月至2018年7月，Mekhail先生担任个人护理产品公司Edgewell Personal Care的美洲Vice President。他曾于2015年7月至2017年4月担任Edgewell Personal Care拉丁美洲私人品牌集团和Vice President的Vice President兼总经理。Mekhail从2013年11月到2015年7月担任Energizer亚太区Vice President，该公司被Edgewell收购。他从2003年到2013年在Energizer担任其他越来越负责的营销角色。Mekhail先生还从1996年到2003年在辉瑞公司和Warner Lambert公司担任销售与市场营销职务。2000年，他为辉瑞公司从澳大利亚搬到美国。Mekhail先生在埃及坦塔大学（Tanta University）获得制药科学学士学位，并在澳大利亚墨尔本的RMIT大学（RMIT University）获得工商管理硕士学位。
- Adel Mekhail,was appointed to the position of Executive Vice President of Marketing & Sales for the Company in May 2019. From April 2017 to July 2018, Mr. Mekhail served as Vice President, Americas at Edgewell Personal Care Company, a personal care products company, and from July 2015 to April 2017 he served as Vice President and General Manager, Private Brands Group and Vice President, Latin America. From November 2013 to July 2015, Mr. Mekhail served as Vice President, Asia Pacific at Energizer. He held other increasingly responsible marketing roles at Energizer from 2003 to 2013. Mr. Mekhail also served in sales and marketing roles for Pfizer and Warner Lambert from 1996 to 2003. In 2000, he moved from Australia to the United States for Pfizer. Mr. Mekhail earned his B.S. in Pharmaceutical Sciences from Tanta University in Egypt and his M.B.A. from RMIT University in Melbourne, Australia.
- Ronald M. Lombardi
Ronald M. Lombardi，他是首席财务官，曾一直担任公司的首席财务官（2010年12月以来）。加入公司之前，他曾任职Medtech Group Holdings公司（组件和合同医疗设备制造商），担任首席财务官（从2010年10月到2010年12月）。从2009年10月到2010年10月，他曾担任 Waterbury International Holdings公司（特种化工和害虫控制业务）的首席财务官。他曾任职Cannondale Sports Group（体育用品和服装制造公司），担任首席运营官（从2008年8月到2009年10月），以及高级副总裁兼首席财务官（从2004年3月到2008年8月）。从2000年到2004年，他曾担任Gerber Scientific公司的多种职务，包括Gerber Scientific公司的戈贝尔科伯恩光学部门的副总裁兼首席财务官，以及Gerber Scientific公司的财务预算及分析董事。他此前曾任职Emerson Electric公司、Scovill Fasteners公司、Go/Dan Industries公司。他持有Springfield College的学士学位，以及American International College的工商管理硕士学位。他是注册会计师。
Ronald M. Lombardi,Elected Chair of the Board in May 2017 and has served as a director and as President and Chief Executive Officer of the Company since June 2015;Served as Chief Financial Officer of the Company from December 2010 until November 2015;Employed by Medtech Group Holdings, a components and contract medical device manufacturer, as Chief Financial Officer, prior to joining the Company, from October 2010 to December 2010;Served as the Chief Financial Officer of Waterbury International Holdings, a specialty chemical and pest control business, from October 2009 to October 2010;Employed by Cannondale Sports Group, a sporting goods and apparel manufacturing company, as Chief Operating Officer from August 2008 to October 2009 and as Senior Vice President and Chief Financial Officer from March 2004 to August 2008;Served in various roles at Gerber Scientific Inc., including Vice President and Chief Financial Officer of Gerber Scientific Inc.'s Gerber Coburn Optical Division and Director of Financial Planning and Analysis from 2000 to 2004;Previously employed by Emerson Electric, Scovill Fasteners, Inc. and Go/Dan Industries;Mr. Lombardi earned a B.S. from Springfield College and an M.B.A. from American International College and has been a licensed CPA.- Ronald M. Lombardi，他是首席财务官，曾一直担任公司的首席财务官（2010年12月以来）。加入公司之前，他曾任职Medtech Group Holdings公司（组件和合同医疗设备制造商），担任首席财务官（从2010年10月到2010年12月）。从2009年10月到2010年10月，他曾担任 Waterbury International Holdings公司（特种化工和害虫控制业务）的首席财务官。他曾任职Cannondale Sports Group（体育用品和服装制造公司），担任首席运营官（从2008年8月到2009年10月），以及高级副总裁兼首席财务官（从2004年3月到2008年8月）。从2000年到2004年，他曾担任Gerber Scientific公司的多种职务，包括Gerber Scientific公司的戈贝尔科伯恩光学部门的副总裁兼首席财务官，以及Gerber Scientific公司的财务预算及分析董事。他此前曾任职Emerson Electric公司、Scovill Fasteners公司、Go/Dan Industries公司。他持有Springfield College的学士学位，以及American International College的工商管理硕士学位。他是注册会计师。
- Ronald M. Lombardi,Elected Chair of the Board in May 2017 and has served as a director and as President and Chief Executive Officer of the Company since June 2015;Served as Chief Financial Officer of the Company from December 2010 until November 2015;Employed by Medtech Group Holdings, a components and contract medical device manufacturer, as Chief Financial Officer, prior to joining the Company, from October 2010 to December 2010;Served as the Chief Financial Officer of Waterbury International Holdings, a specialty chemical and pest control business, from October 2009 to October 2010;Employed by Cannondale Sports Group, a sporting goods and apparel manufacturing company, as Chief Operating Officer from August 2008 to October 2009 and as Senior Vice President and Chief Financial Officer from March 2004 to August 2008;Served in various roles at Gerber Scientific Inc., including Vice President and Chief Financial Officer of Gerber Scientific Inc.'s Gerber Coburn Optical Division and Director of Financial Planning and Analysis from 2000 to 2004;Previously employed by Emerson Electric, Scovill Fasteners, Inc. and Go/Dan Industries;Mr. Lombardi earned a B.S. from Springfield College and an M.B.A. from American International College and has been a licensed CPA.
- Christine Sacco
Christine Sacco，2012年1月，她被任命为首席财政官；她受到任命之前，2008年1月1日起，她是公司的副总裁和运营总监；2011年1月1日志2012年3月30日，她在公司担任首席会计师；2002年10月至2008年1月，在加入公司之前，她在Alpharma担任副总裁、财务总监和财务报表董事。Alpharma，曾经是一家国营企业，现在是Pfizer附属公司，负责提供大量的医药和动物健康产品、她是注册公共会计师，获有圣托马斯阿奎那斯学院会计学学士学位。
Christine Sacco,was appointed to the position of Chief Financial Officer and Chief Operating Officer for the Company in January 2025. She served as the Chief Financial Officer of the Company from September 2016 until January 2025. Ms. Sacco joined the Company from Boulder Brands, Inc., a health and wellness food manufacturer, where she served as the Chief Financial Officer and Treasurer from January 2012 to January 2016 and Vice President and Controller from January 2008 to January 2012, including Principal Accounting Officer from January 2011 to March 2012. From October 2002 until January 2008, she held positions of increasing financial responsibility with Alpharma, Inc., a global specialty pharma company, where she last held the position of Vice President, Treasurer. Ms. Sacco began her career with Ernst & Young and worked for five years in the Audit and Assurance group. She holds a B.S. in accounting from St. Thomas Aquinas College and has been a licensed CPA.- Christine Sacco，2012年1月，她被任命为首席财政官；她受到任命之前，2008年1月1日起，她是公司的副总裁和运营总监；2011年1月1日志2012年3月30日，她在公司担任首席会计师；2002年10月至2008年1月，在加入公司之前，她在Alpharma担任副总裁、财务总监和财务报表董事。Alpharma，曾经是一家国营企业，现在是Pfizer附属公司，负责提供大量的医药和动物健康产品、她是注册公共会计师，获有圣托马斯阿奎那斯学院会计学学士学位。
- Christine Sacco,was appointed to the position of Chief Financial Officer and Chief Operating Officer for the Company in January 2025. She served as the Chief Financial Officer of the Company from September 2016 until January 2025. Ms. Sacco joined the Company from Boulder Brands, Inc., a health and wellness food manufacturer, where she served as the Chief Financial Officer and Treasurer from January 2012 to January 2016 and Vice President and Controller from January 2008 to January 2012, including Principal Accounting Officer from January 2011 to March 2012. From October 2002 until January 2008, she held positions of increasing financial responsibility with Alpharma, Inc., a global specialty pharma company, where she last held the position of Vice President, Treasurer. Ms. Sacco began her career with Ernst & Young and worked for five years in the Audit and Assurance group. She holds a B.S. in accounting from St. Thomas Aquinas College and has been a licensed CPA.